{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T23:21:58Z","timestamp":1794871318002,"version":"4.9.1"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,7]]},"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>Tolerance induction is an important goal in the field of organ transplantation. We have sequentially modified our conditioning regimen for induction of donor-specific tolerance in recipients of major histocompatibility complex-mismatched combined kidney and bone marrow transplantation (CKBMT).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>From December 2011 to May 2017, 8 major histocompatibility complex-mismatched patients received CKBMT. The initial conditioning regimen (protocol 1) consisted of cyclophosphamide (CP), rituximab, rabbit antithymocyte globulin, and thymic irradiation. Tacrolimus and steroids were used for the maintenance of immunosuppression (IS).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>This regimen was complicated by transient acute kidney injury, which has been the major clinical feature of engraftment syndrome and side effects of CP, although one of 2 subjects successfully discontinued his IS for 14 months. The conditioning regimen was modified by reducing the CP dose and adding fludarabine (protocol 2). The final modification was reducing the fludarabine and rabbit antithymocyte globulin doses (protocol 3). Mixed chimerism, detected by the short tandem repeat method, was achieved transiently in all subjects for 3\u201320 weeks. Among the 3 subjects treated with protocol 2, IS was successfully discontinued for &gt;35 months in one subject, but the other 2 subjects suffered from severe BK virus-associated nephritis. All 3 subjects treated with protocol 3 tolerated the protocol well and have successfully discontinued IS for &gt;4\u201341 months. Interestingly, de novo donor-specific antibody was not detected in any subject during all the follow-up periods.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions.<\/jats:title>\n            <jats:p>Our clinical trial has shown that long-term renal allograft survival without maintenance IS can be achieved by induction of mixed chimerism following CKBMT.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/tp.0000000000003006","type":"journal-article","created":{"date-parts":[[2019,10,20]],"date-time":"2019-10-20T17:43:27Z","timestamp":1571593407000},"page":"1472-1482","source":"Crossref","is-referenced-by-count":40,"title":["Inducing Transient Mixed Chimerism for Allograft Survival Without Maintenance Immunosuppression With Combined Kidney and Bone Marrow Transplantation: Protocol Optimization"],"prefix":"10.1097","volume":"104","author":[{"given":"Kyo Won","family":"Lee","sequence":"first","affiliation":[{"name":"Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Berm","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea."},{"name":"Samsung Advanced Institute for Health Sciences & Technology(SAIHST), Graduate School, Department of Health Sciences & Technology, Sungkyunkwan University, Seoul, Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyojun","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine & Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeongbeen","family":"Kwon","sequence":"additional","affiliation":[{"name":"Samsung Advanced Institute for Health Sciences & Technology(SAIHST), Graduate School, Department of Health Sciences & Technology, Sungkyunkwan University, Seoul, Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Soo","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyeong Sik","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Jae","family":"Chung","sequence":"additional","affiliation":[{"name":"Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Soo","family":"Rhu","sequence":"additional","affiliation":[{"name":"Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sooin","family":"Choi","sequence":"additional","affiliation":[{"name":"Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghee Young","family":"Kwon","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Soonchunhyang University Hospital Cheonan, Soonchunhyang University College of Medicine, Cheonan, Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Jin","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Surgery, VHS Medical Center, Seoul, Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Suk","family":"Kang","sequence":"additional","affiliation":[{"name":"Department of Surgery, VHS Medical Center, Seoul, Korea."},{"name":"Department of Laboratory Medicine & Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chul Won","family":"Jung","sequence":"additional","affiliation":[{"name":"Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eui-Cheol","family":"Shin","sequence":"additional","affiliation":[{"name":"Laboratory of Immunology and Infectious Diseases, Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuo","family":"Kawai","sequence":"additional","affiliation":[{"name":"Department of Surgery, Center for Transplantation Sciences, Massachusetts General Hospital, Harvard Medical School, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Joo","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Won","family":"Joh","sequence":"additional","affiliation":[{"name":"Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20231002","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/172603a0","article-title":"Actively acquired tolerance of foreign cells.","volume":"172","author":"Billingham","year":"1953","journal-title":"Nature"},{"key":"R2-20231002","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1056\/NEJMoa021744","article-title":"Chronic renal failure after transplantation of a nonrenal organ.","volume":"349","author":"Ojo","year":"2003","journal-title":"N Engl J Med"},{"key":"R3-20231002","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1007\/s40265-013-0089-0","article-title":"Adverse effects of immunosuppressant drugs upon airway epithelial cell and mucociliary clearance: implications for lung transplant recipients.","volume":"73","author":"Pazetti","year":"2013","journal-title":"Drugs"},{"key":"R4-20231002","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/cei.12969","article-title":"Chimerism-based tolerance in organ transplantation: preclinical and clinical studies.","volume":"189","author":"Oura","year":"2017","journal-title":"Clin Exp Immunol"},{"key":"R5-20231002","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1056\/NEJMoa071074","article-title":"HLA-mismatched renal transplantation without maintenance immunosuppression.","volume":"358","author":"Kawai","year":"2008","journal-title":"N Engl J Med"},{"key":"R6-20231002","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1097\/TP.0b013e3181ffbaff","article-title":"Mixed chimerism, lymphocyte recovery, and evidence for early donor-specific unresponsiveness in patients receiving combined kidney and bone marrow transplantation to induce tolerance.","volume":"90","author":"LoCascio","year":"2010","journal-title":"Transplantation"},{"key":"R7-20231002","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1097\/TP.0b013e31820a3068","article-title":"Long-term follow-up of recipients of combined human leukocyte antigen-matched bone marrow and kidney transplantation for multiple myeloma with end-stage renal disease.","volume":"91","author":"Spitzer","year":"2011","journal-title":"Transplantation"},{"key":"R8-20231002","doi-asserted-by":"crossref","first-page":"124ra28","DOI":"10.1126\/scitranslmed.3003509","article-title":"Chimerism and tolerance without GVHD or engraftment syndrome in HLA-mismatched combined kidney and hematopoietic stem cell transplantation.","volume":"4","author":"Leventhal","year":"2012","journal-title":"Sci Transl Med"},{"key":"R9-20231002","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1111\/j.1600-6143.2012.03992.x","article-title":"Tolerance and withdrawal of immunosuppressive drugs in patients given kidney and hematopoietic cell transplants.","volume":"12","author":"Scandling","year":"2012","journal-title":"Am J Transplant"},{"key":"R10-20231002","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/TP.0b013e3182782fc1","article-title":"Tolerance induction in HLA disparate living donor kidney transplantation by donor stem cell infusion: durable chimerism predicts outcome.","volume":"95","author":"Leventhal","year":"2013","journal-title":"Transplantation"},{"key":"R11-20231002","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1111\/ajt.12731","article-title":"Long-term results in recipients of combined HLA-mismatched kidney and bone marrow transplantation without maintenance immunosuppression.","volume":"14","author":"Kawai","year":"2014","journal-title":"Am J Transplant"},{"key":"R12-20231002","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/ajt.13091","article-title":"Chimerism, graft survival, and withdrawal of immunosuppressive drugs in HLA matched and mismatched patients after living donor kidney and hematopoietic cell transplantation.","volume":"15","author":"Scandling","year":"2015","journal-title":"Am J Transplant"},{"key":"R13-20231002","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.clim.2017.07.024","article-title":"Six years\u2019 experience of tolerance induction in renal transplantation using stem cell therapy.","volume":"187","author":"Vanikar","year":"2018","journal-title":"Clin Immunol"},{"key":"R14-20231002","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/00007890-199501000-00018","article-title":"Mixed allogeneic chimerism and renal allograft tolerance in cynomolgus monkeys.","volume":"59","author":"Kawai","year":"1995","journal-title":"Transplantation"},{"key":"R15-20231002","doi-asserted-by":"crossref","first-page":"a015529","DOI":"10.1101\/cshperspect.a015529","article-title":"Induction of tolerance through mixed chimerism.","volume":"4","author":"Sachs","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"key":"R16-20231002","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1084\/jem.147.3.700","article-title":"Transplantation tolerance in adult rats using total lymphoid irradiation: permanent survival of skin, heart, and marrow allografts.","volume":"147","author":"Slavin","year":"1978","journal-title":"J Exp Med"},{"key":"R17-20231002","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1097\/00007890-199609270-00026","article-title":"Evidence that the continued presence of the organ graft and not peripheral donor microchimerism is essential for maintenance of tolerance to alloantigen in vivo in anti-CD4 treated recipients.","volume":"62","author":"Hamano","year":"1996","journal-title":"Transplantation"},{"key":"R18-20231002","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0140-6736(98)11135-2","article-title":"Mixed lymphohaemopoietic chimerism and graft-versus-lymphoma effects after non-myeloablative therapy and HLA-mismatched bone-marrow transplantation.","volume":"353","author":"Sykes","year":"1999","journal-title":"Lancet"},{"key":"R19-20231002","doi-asserted-by":"crossref","first-page":"166","DOI":"10.12659\/AOT.902266","article-title":"The impact of donor-specific anti-human leukocyte antigen (HLA) antibody rebound on the risk of antibody mediated rejection in sensitized kidney transplant recipients.","volume":"22","author":"Lee","year":"2017","journal-title":"Ann Transplant"},{"key":"R20-20231002","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.transproceed.2016.01.027","article-title":"Short-term outcomes of ABO-incompatible living donor kidney transplantation with uniform protocol: significance of baseline anti-ABO titer.","volume":"48","author":"Lee","year":"2016","journal-title":"Transplant Proc"},{"key":"R21-20231002","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1111\/j.1600-6143.2011.03572.x","article-title":"Acute renal endothelial injury during marrow recovery in a cohort of combined kidney and bone marrow allografts.","volume":"11","author":"Farris","year":"2011","journal-title":"Am J Transplant"},{"key":"R22-20231002","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1007\/s00277-012-1462-x","article-title":"A randomized comparison of cyclophosphamide vs. reduced dose cyclophosphamide plus fludarabine for allogeneic hematopoietic cell transplantation in patients with aplastic anemia and hypoplastic myelodysplastic syndrome.","volume":"91","author":"Kim","year":"2012","journal-title":"Ann Hematol"},{"key":"R23-20231002","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1053\/bbmt.2001.v7.pm11787527","article-title":"Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.","volume":"7","author":"Mapara","year":"2001","journal-title":"Biol Blood Marrow Transplant"},{"key":"R24-20231002","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1111\/j.1600-6143.2004.00523.x","article-title":"CD154 blockade for induction of mixed chimerism and prolonged renal allograft survival in nonhuman primates.","volume":"4","author":"Kawai","year":"2004","journal-title":"Am J Transplant"},{"key":"R25-20231002","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1097\/01.tp.0000234786.26511.a4","article-title":"Monitoring antidonor alloantibodies as a predictive assay for renal allograft tolerance\/long-term observations in nonhuman primates.","volume":"82","author":"Boskovic","year":"2006","journal-title":"Transplantation"},{"key":"R26-20231002","doi-asserted-by":"crossref","first-page":"86ra51","DOI":"10.1126\/scitranslmed.3002093","article-title":"Host alloreactive memory T cells influence tolerance to kidney allografts in nonhuman primates.","volume":"3","author":"Nadazdin","year":"2011","journal-title":"Sci Transl Med"},{"key":"R27-20231002","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/ajt.15086","article-title":"Summary of the Third International Workshop on Clinical Tolerance.","volume":"19","author":"Kawai","year":"2019","journal-title":"Am J Transplant"},{"key":"R28-20231002","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/cei.12988","article-title":"Immune monitoring as prerequisite for transplantation tolerance trials.","volume":"189","author":"Behnam Sani","year":"2017","journal-title":"Clin Exp Immunol"},{"key":"R29-20231002","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.it.2017.07.008","article-title":"Mechanisms of mixed chimerism-based transplant tolerance.","volume":"38","author":"Zuber","year":"2017","journal-title":"Trends Immunol"},{"key":"R30-20231002","doi-asserted-by":"crossref","first-page":"e86419","DOI":"10.1172\/jci.insight.86419","article-title":"Induced regulatory T cells in allograft tolerance via transient mixed chimerism.","volume":"1","author":"Hotta","year":"2016","journal-title":"JCI Insight"},{"key":"R31-20231002","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1007\/s10620-005-3065-z","article-title":"Acute icteric hepatitis induced by a short course of low-dose cyclophosphamide in a patient with lupus nephritis.","volume":"50","author":"Muratori","year":"2005","journal-title":"Dig Dis Sci"},{"key":"R32-20231002","doi-asserted-by":"crossref","first-page":"345","DOI":"10.12659\/AJCR.889401","article-title":"Low-dose cyclophosphamide-induced acute hepatotoxicity.","volume":"14","author":"Subramaniam","year":"2013","journal-title":"Am J Case Rep"},{"key":"R33-20231002","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1097\/TP.0b013e3181668ecc","article-title":"SV40 infection associated with rituximab treatment after kidney transplantation in nonhuman primates.","volume":"85","author":"Maki","year":"2008","journal-title":"Transplantation"},{"key":"R34-20231002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15171\/jnp.2016.01","article-title":"Place of mTOR inhibitors in management of BKV infection after kidney transplantation.","volume":"5","author":"Jouve","year":"2016","journal-title":"J Nephropathol"},{"issue":"2S Suppl 1","key":"R35-20231002","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1097\/TP.0000000000001777","article-title":"The role of mTOR inhibitors in the management of viral infections: a review of current literature.","volume":"102","author":"Bowman","year":"2018","journal-title":"Transplantation"},{"key":"R36-20231002","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/ajt.13541","article-title":"BK polyomavirus replication in renal tubular epithelial cells is inhibited by sirolimus, but activated by tacrolimus through a pathway involving FKBP-12.","volume":"16","author":"Hirsch","year":"2016","journal-title":"Am J Transplant"},{"key":"R37-20231002","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1111\/j.1600-6143.2010.03066.x","article-title":"Infection with the intracellular bacterium, listeria monocytogenes, overrides established tolerance in a mouse cardiac allograft model.","volume":"10","author":"Wang","year":"2010","journal-title":"Am J Transplant"},{"key":"R38-20231002","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/j.1600-6143.2011.03476.x","article-title":"IL-6 induced by staphylococcus aureus infection prevents the induction of skin allograft acceptance in mice.","volume":"11","author":"Ahmed","year":"2011","journal-title":"Am J Transplant"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000003006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T05:12:18Z","timestamp":1696223538000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000003006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":38,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000003006","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]}}}